Literature DB >> 20508131

mTORC1-mediated cell proliferation, but not cell growth, controlled by the 4E-BPs.

Ryan J O Dowling1, Ivan Topisirovic, Tommy Alain, Michael Bidinosti, Bruno D Fonseca, Emmanuel Petroulakis, Xiaoshan Wang, Ola Larsson, Anand Selvaraj, Yi Liu, Sara C Kozma, George Thomas, Nahum Sonenberg.   

Abstract

The mammalian target of rapamycin complex 1 (mTORC1) integrates mitogen and nutrient signals to control cell proliferation and cell size. Hence, mTORC1 is implicated in a large number of human diseases--including diabetes, obesity, heart disease, and cancer--that are characterized by aberrant cell growth and proliferation. Although eukaryotic translation initiation factor 4E-binding proteins (4E-BPs) are critical mediators of mTORC1 function, their precise contribution to mTORC1 signaling and the mechanisms by which they mediate mTORC1 function have remained unclear. We inhibited the mTORC1 pathway in cells lacking 4E-BPs and analyzed the effects on cell size, cell proliferation, and cell cycle progression. Although the 4E-BPs had no effect on cell size, they inhibited cell proliferation by selectively inhibiting the translation of messenger RNAs that encode proliferation-promoting proteins and proteins involved in cell cycle progression. Thus, control of cell size and cell cycle progression appear to be independent in mammalian cells, whereas in lower eukaryotes, 4E-BPs influence both cell growth and proliferation.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20508131      PMCID: PMC2893390          DOI: 10.1126/science.1187532

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  25 in total

1.  Raptor, a binding partner of target of rapamycin (TOR), mediates TOR action.

Authors:  Kenta Hara; Yoshiko Maruki; Xiaomeng Long; Ken-ichi Yoshino; Noriko Oshiro; Sujuti Hidayat; Chiharu Tokunaga; Joseph Avruch; Kazuyoshi Yonezawa
Journal:  Cell       Date:  2002-07-26       Impact factor: 41.582

Review 2.  Upstream and downstream of mTOR.

Authors:  Nissim Hay; Nahum Sonenberg
Journal:  Genes Dev       Date:  2004-08-15       Impact factor: 11.361

3.  p53-dependent translational control of senescence and transformation via 4E-BPs.

Authors:  Emmanuel Petroulakis; Armen Parsyan; Ryan J O Dowling; Olivier LeBacquer; Yvan Martineau; Michael Bidinosti; Ola Larsson; Tommy Alain; Liwei Rong; Yaël Mamane; Marilene Paquet; Luc Furic; Ivan Topisirovic; David Shahbazian; Mark Livingstone; Mauro Costa-Mattioli; Jose G Teodoro; Nahum Sonenberg
Journal:  Cancer Cell       Date:  2009-11-06       Impact factor: 31.743

Review 4.  Does the ribosome translate cancer?

Authors:  Davide Ruggero; Pier Paolo Pandolfi
Journal:  Nat Rev Cancer       Date:  2003-03       Impact factor: 60.716

5.  Insulin-dependent stimulation of protein synthesis by phosphorylation of a regulator of 5'-cap function.

Authors:  A Pause; G J Belsham; A C Gingras; O Donzé; T A Lin; J C Lawrence; N Sonenberg
Journal:  Nature       Date:  1994-10-27       Impact factor: 49.962

6.  Characterizing the interaction of the mammalian eIF4E-related protein 4EHP with 4E-BP1.

Authors:  Andrew R Tee; Jennifer A Tee; John Blenis
Journal:  FEBS Lett       Date:  2004-04-23       Impact factor: 4.124

Review 7.  eIF-4E expression and its role in malignancies and metastases.

Authors:  Arrigo De Benedetti; Jeremy R Graff
Journal:  Oncogene       Date:  2004-04-19       Impact factor: 9.867

8.  Identification of a novel inhibitor of mitogen-activated protein kinase kinase.

Authors:  M F Favata; K Y Horiuchi; E J Manos; A J Daulerio; D A Stradley; W S Feeser; D E Van Dyk; W J Pitts; R A Earl; F Hobbs; R A Copeland; R L Magolda; P A Scherle; J M Trzaskos
Journal:  J Biol Chem       Date:  1998-07-17       Impact factor: 5.157

Review 9.  Not all substrates are treated equally: implications for mTOR, rapamycin-resistance and cancer therapy.

Authors:  Andrew Y Choo; John Blenis
Journal:  Cell Cycle       Date:  2009-02-18       Impact factor: 4.534

10.  Differences in the way a mammalian cell and yeast cells coordinate cell growth and cell-cycle progression.

Authors:  Ian Conlon; Martin Raff
Journal:  J Biol       Date:  2003-04-24
View more
  339 in total

1.  S6 kinase 1 is required for rapamycin-sensitive liver proliferation after mouse hepatectomy.

Authors:  Catherine Espeillac; Claudia Mitchell; Séverine Celton-Morizur; Céline Chauvin; Vonda Koka; Cynthia Gillet; Jeffrey H Albrecht; Chantal Desdouets; Mario Pende
Journal:  J Clin Invest       Date:  2011-07       Impact factor: 14.808

2.  High-dose rapamycin induces apoptosis in human cancer cells by dissociating mTOR complex 1 and suppressing phosphorylation of 4E-BP1.

Authors:  Paige Yellen; Mahesh Saqcena; Darin Salloum; Jiangnan Feng; Angela Preda; Limei Xu; Vanessa Rodrik-Outmezguine; David A Foster
Journal:  Cell Cycle       Date:  2011-11-15       Impact factor: 4.534

Review 3.  Regulation of TOR by small GTPases.

Authors:  Raúl V Durán; Michael N Hall
Journal:  EMBO Rep       Date:  2012-02-01       Impact factor: 8.807

4.  Emerging therapeutics targeting mRNA translation.

Authors:  Abba Malina; John R Mills; Jerry Pelletier
Journal:  Cold Spring Harb Perspect Biol       Date:  2012-04-01       Impact factor: 10.005

Review 5.  mTOR signaling in growth control and disease.

Authors:  Mathieu Laplante; David M Sabatini
Journal:  Cell       Date:  2012-04-13       Impact factor: 41.582

Review 6.  Translational regulation in nutrigenomics.

Authors:  Botao Liu; Shu-Bing Qian
Journal:  Adv Nutr       Date:  2011-11-03       Impact factor: 8.701

7.  Mnk earmarks eIF4E for cancer therapy.

Authors:  Nissim Hay
Journal:  Proc Natl Acad Sci U S A       Date:  2010-08-02       Impact factor: 11.205

8.  Bending the path to TOR.

Authors:  Brian M Wiczer; Adem Kalender; George Thomas
Journal:  Nat Cell Biol       Date:  2010-11       Impact factor: 28.824

Review 9.  Aging and TOR: interwoven in the fabric of life.

Authors:  Zelton Dave Sharp
Journal:  Cell Mol Life Sci       Date:  2010-10-21       Impact factor: 9.261

10.  Chemoproteomic Profiling Uncovers CDK4-Mediated Phosphorylation of the Translational Suppressor 4E-BP1.

Authors:  Dylan C Mitchell; Arya Menon; Amanda L Garner
Journal:  Cell Chem Biol       Date:  2019-05-02       Impact factor: 8.116

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.